[1] Sun JH, Luo Q, Liu LL, et al.Liver cancer stem cell markers: Progression and therapeutic implications[J]. World J Gastroenterol, 2016, 22(13): 3547-3557. [2] Anwaanwna D, Singh SK, Singh S, et al.Challenges in liver cancer and possible treatment approaches[J]. Biochim Biophys Acta Rev Cancer, 2020, 1873(1): 188314. [3] Stockwell BR, Friedmann angeli JP, Bayir H, et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease[J]. Cell, 2017, 171(2): 273-285. [4] Li S, Huang Y.Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy[J]. Clin Transl Oncol, 2022, 24(1): 1-12. [5] Zhao Y, Li Y, Zhang R, et al.The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy[J]. Onco Targets Ther, 2020, (13): 5429-5441. [6] Liu M, Fan Y, Li D, et al.Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis[J]. Mol Oncol, 2021, 15(8): 2084-2105. [7] Liu CY, Chen KF, Chen PJ.Treatment of Liver Cancer[J]. Cold Spring Harb Perspect Med, 2015, 5(9): a021535. [8] Teoh SL, Das S.The Emerging Role of the Hippo Pathway in Lung Cancers: Clinical Implications[J]. Curr Drug Targets, 2017, 18(16): 1880-1892. [9] Desai A, Mohammed T, Patel KN, et al.5-Fluorouracil Rechallenge After Cardiotoxicity[J]. Am J Case Rep, 2020, (21): e924446. [10] Liu Z, Zhang Y, Xiang Y, et al.Small-Molecule PROTACs for Cancer Immunotherapy[J]. Molecules, 2022, 27(17): 5439. [11] Capelletti MM, Manceau H, Puy H, et al.Ferroptosis in Liver Diseases: An Overview[J]. Int J Mol Sci, 2020, 21(14): 4908. [12] Wang L, Liu Y, Du T, et al.ATF3 promotes erastin-induced ferroptosis by suppressing system Xc[J]. Cell Death Differ, 2020, 27(2): 662-675. |